Telemedicine in neuro-ophthalmology
- PMID: 34419978
- DOI: 10.1097/ICU.0000000000000800
Telemedicine in neuro-ophthalmology
Abstract
Purpose of review: The COVID-19 public health emergency accelerated the adoption of telemedicine in neuro-ophthalmology. This review surveys the current telemedicine landscape and discusses associated limitations and opportunities.
Recent findings: Logistic considerations and regulatory changes related to the COVID-19 pandemic have spurred a proliferation of tele-neuro-ophthalmic practice. One significant benefit of telemedicine is increased access to the limited number of neuro-ophthalmologists in the country. Certain elements of the neuro-ophthalmic examination can be ascertained during a video visit or through the use of mobile applications. However, data quality can be limited and more direct evaluation of the fundus currently requires the implementation of imaging techniques, such as fundus photography and/or optical coherence tomography. For cases that require it, a 'hybrid' model can be adopted in which patients physically present to designated locations for testing and subsequently participate in televisit with the physician to discuss the assessment and plan.
Summary: Telemedicine provides an alternate pathway for patients to access the limited resource of neuro-ophthalmic care, and it will likely persist beyond the current COVID-19 pandemic. It has some limitations currently but continued progress in technologic, legal, and reimbursement strategies will hopefully facilitate further adoption.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Field MJ, Institute of Medicine (US) Committee on Evaluating Clinical Applications of Telemedicine, editors. Telemedicine: a guide to assessing telecommunications in healthcare. The National Academies Collection. 1996.
-
- Barnett ML, Ray KN, Souza J, Mehrotra A. Trends in telemedicine use in a large commercially insured population, 2005–2017. JAMA 2018; 320:2147–2149.
-
- Wechsler LR. Advantages and limitations of teleneurology. JAMA Neurol 2015; 72:349–354.
-
- Gupta A, Caverano J, Sun JK, Silva PS. Evidence for telemedicine in diabetic retinal disease. Semin Ophthalmol 2017; 32:22–28.
-
- Wang SK, Callaway NF, Wallenstein MB, et al. SUNDROP: six years of screening for retinopathy of prematurity with telemedicine. Can J Ophthalmol 2015; 50:101–106.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
